Eurofins Clinical Diagnostics Patients icon

Over 65,000

Patients per day

 Eurofins Clinical Diagnostics Test per Year icon

Over 110 million

Tests performed per year

 Eurofins Clinical Diagnostics Sample Collection icon

More than 800

Sample collection centres

 Eurofins Clinical Diagnostics City laboratories icon

More than 250

Clinical diagnostics laboratories

 Eurofins Clinical Diagnostics Hospitals con

70 On-site

Hospital laboratories

 Eurofins Clinical Diagnostics Councelling icon

From sample pick-up

To medical counselling

Women's Health by Eurofins Clinical Diagnostics pie chart

Hormonal disorders can explain early or delayed sexual development and menstrual irregularities. We offer testing to help diagnose those disorders as well as  thrombosis risk profiles for those taking oral contraception. Sexually transmitted disease (STDs) panels for fast and easy diagnosis are also available at Eurofins clinical diagnostics laboratories.


For women of reproductive age, we offer hormonal and genetic testing that can help in the diagnosis of conditions that influence fertility. We also specialise in genetic, hormonal and immunological tests to help identify and manage the cause of miscarriages as soon as possible. For women who are experiencing difficulties in getting pregnant, we service medically assisted procreation (MAP) centres with a broad variety of tests.


Eurofins Clinical Diagnostics laboratories are leaders in prenatal testing, offering non-invasive methods (NIPT) for common aneuploidies as well as for de novo and inherited disorders. We also perform testing for fetomaternal infections, pre-eclampsia diagnosis and RhD status.


Breast and ovarian cancers are among the most common cancers in women. From predisposition testing for those looking for reassurance, to determination of biomarkers for prognosis to specialised testing for patients undergoing cancer treatment, we support healthcare professionals to provide the best care to their patients.


Our bone resorption markers testing can detect products of bone remodelling in blood and urine that could indicate an increased risk of bone fractures. These tests are also used to monitor treatment efficiency for women undergoing drug therapy for osteoporosis.

Logo

Eurofins Clinical Diagnostics results that deliver